Advertisement

Surgical Endoscopy

, Volume 29, Issue 9, pp 2669–2674 | Cite as

Remission of type 2 diabetes after omega loop gastric bypass for morbid obesity

  • Martino Guenzi
  • Gustavo Arman
  • Cédric Rau
  • Cristiana Cordun
  • David Moszkowicz
  • Thibault Voron
  • Jean-Marc Chevallier
Article

Abstract

Background

Roux-en-Y gastric bypass (RYGBP) is a validated technique for the treatment of morbid obesity and results in a significant rate of remission of type 2 diabetes (T2D). Omega gastric bypass (OGBP) is an effective and simpler alternative for weight loss, but its effect on T2D is unclear.

Methods

Between December 2006 and September 2012, 804 laparoscopic OGBPs were carried out in our centre. Among these, 100 (12.4 %) patients had T2D at the time of the intervention. Remission of T2D was defined by a glycated haemoglobin (HbA1c) level of <6 % without concomitant treatment.

Results

Postoperative follow-up was completed by 81 patients (mean age: 49 ± 11 years; mean weight at surgery: 133 ± 29 kg; mean body mass index (BMI): 47 ± 9 kg/m2). Mean preoperative HbA1c was 8 ± 2 g/dL. Before OGBP, seven patients (9 %) had received no oral hypoglycaemic treatment, 30 (37 %) had received monotherapy, 26 (32 %) bitherapy, six (7 %) tritherapy and 12 (15 %) patients had used insulin. Over a mean follow-up of 26 months (range 1–75), mean weight decreased to 94 ± 23 kg and mean BMI to 35 kg/m2. Seventy-one (88 %) patients had complete remission of T2D and the other 10 (12 %) had reduced their treatment. Seven patients (58 %) initially treated with insulin no longer required this treatment. Mean time to remission of T2D for patients receiving one or more oral therapies versus insulin was 6.9 versus 17.9 months.

Conclusions

OMBP is effective treatment for obesity in terms of weight loss and remission of T2D.

Keywords

Bariatric surgery Gastric bypass Glycated haemoglobin Obesity Omega loop Type 2 diabetes 

Notes

Disclosures

Drs. Guenzi, Arman, Rau, Cordun, Moszkowicz, Voron and Chevallier have no conflicts of interest or financial ties to disclose.

References

  1. 1.
    Sjostrom CD, Lissner L, Wedel H, Sjostrom L (1999) Reduction in incidence of diabetes, hypertension, and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res 7(5):477–484CrossRefPubMedGoogle Scholar
  2. 2.
    Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122(3):248–256CrossRefPubMedGoogle Scholar
  3. 3.
    Pories WJ, Mac Donald KG, Morgan EJ Jr, Sinha MK, Dohm GL, Swanson MS et al (1992) Surgical treatment of obesity and its effect on diabetes: 10-year follow-up. Am J Clin Nutr 55(2 Suppl):582S–585SPubMedGoogle Scholar
  4. 4.
    Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, Eid GM, Mattar S, Ramanathan R, Barinas-Mitchel E, Rao RH, Kuller L, Kelley D (2003) Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 238(4):467–484PubMedCentralPubMedGoogle Scholar
  5. 5.
    Iaconelli A, Panunzi S, De Gaetano A, Manco M, Guidone C, Leccesi L, Gniuli D, Nanni G, Castagneto M, Ghirlanda G, Mingrone G (2011) Effects of bilio-pancreatic diversion on diabetic complications: a 10-year follow-up. Diabetes Care 34(3):561–567PubMedCentralCrossRefPubMedGoogle Scholar
  6. 6.
    Rutledge R (2001) The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg 11(3):276–280CrossRefPubMedGoogle Scholar
  7. 7.
    Lee WJ, Yu PJ, Wang W, Chen TC, Wei PL, Huang MT (2005) Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial. Ann Surg 242(1):20–28PubMedCentralCrossRefPubMedGoogle Scholar
  8. 8.
    Kim Z, Hur KY (2011) Laparoscopic mini-gastric bypass for type 2 diabetes: the preliminary report. World J Surg 35(3):631–636CrossRefPubMedGoogle Scholar
  9. 9.
    Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K (2004) Bariatric surgery: a systematic review and meta-analysis. JAMA 292(14):1724–1737CrossRefPubMedGoogle Scholar
  10. 10.
    Arterburn DE, Bogart A, Sherwood NE, Sidney S, Coleman KJ, Haneuse S, O’Connor PJ, Theis MK, Campos GM, McCulloch D, Selby J (2013) A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obes Surg 23(1):93–102CrossRefPubMedGoogle Scholar
  11. 11.
    Abbatini F, Rizzello M, Casella G, Alessandri G, Capoccia D, Leonetti F, Basso N (2010) Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc 24(5):1005–1010CrossRefPubMedGoogle Scholar
  12. 12.
    American Diabetes Association, Bantle JP, Wylie-Rosett J, Albright AL, Apovian CM, Clark NG, Franz MJ, Hoogwerf BJ, Lichtenstein AH, Mayer-Davis E, Mooradian AD, Wheeler ML (2008) Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 31(Suppl 1):S61–78Google Scholar
  13. 13.
    American Diabetes Association (2011) Executive summary: standards of medical care in diabetes—2011. Diabetes Care 34(Suppl 1):S4–S10Google Scholar
  14. 14.
    Carbajo M, García-Caballero M, Toledano M, Osorio D, García-Lanza C, Carmona JA (2005) One-anastomosis gastric bypass by laparoscopy: results in the first 209 patients. Obes Surg 15(3):398–404CrossRefPubMedGoogle Scholar
  15. 15.
    Chakhtoura G, Zinzindohoué F, Ghanem Y, Ruseykin I, Dutranoy JC, Chevallier JM (2008) Primary results of laparoscopic mini-gastric bypass in a French obesity-surgery specialized university hospital. Obes Surg 18(9):1130–1133CrossRefPubMedGoogle Scholar
  16. 16.
    Kula KS, Machanda N (2010) Comparison of laparoscopic mini gastric bypass with Roux-en-Y gastric bypass for the treatment of morbid obesity. Surg Obes Relat Dis 6(3):S63–S64CrossRefGoogle Scholar
  17. 17.
    Lee WJ, Lee YC, Ser KH, Su YH, Chen SC (2010) Revisional surgery of laparoscopic mini-gastric bypass: a nine-year follow-up. Surg Obes Relat Dis 6(3):S15CrossRefGoogle Scholar
  18. 18.
    Rutledge R, Walsh TR (2005) Continued excellent results with the mini-gastric bypass: six-year study in 2,410 patients. Obes Surg 15(9):1304–1308CrossRefPubMedGoogle Scholar
  19. 19.
    Wang W, Wei PL, Lee YC, Huang MT, Chiu CC, Lee WJ (2005) Short-term results of laparoscopic mini-gastric bypass. Obes Surg 15(5):648–654CrossRefPubMedGoogle Scholar
  20. 20.
    Fobi M1, Lee H, Igwe D, Felahy B, James E, Stanczyk M, Fobi N (2002) Gastric bypass in patients with BMI < 40 but >32 without life-threatening co-morbidities: preliminary report. Obes Surg 12(1):52–56Google Scholar
  21. 21.
    Huang CK, Shabbir A, Lo CH, Tai CM, Chen YS, Houng JY (2011) Roux-en-Y gastric bypass for the treatment of type II diabetes mellitus in Chinese patients with body mass index of 25–35. Obes Surg 21(9):1344–1349PubMedCentralCrossRefPubMedGoogle Scholar
  22. 22.
    Hayes MT, Hunt LA, Foo J, Tychinskaya Y, Stubbs RS (2011) A model for predicting the resolution of type 2 diabetes in severely obese subjects following Roux-en Y gastric bypass surgery. Obes Surg 21(7):910–916CrossRefPubMedGoogle Scholar
  23. 23.
    Campos GM, Rabl C, Mulligan K, Posselt A, Rogers SJ, Westphalen AC, Lin F, Vittinghoff E (2008) Factors associated with weight loss after gastric bypass. Arch Surg 143(9):877–883PubMedCentralCrossRefPubMedGoogle Scholar
  24. 24.
    Carbonell AM, Wolfe LG, Meador JG, Sugerman HJ, Kellum JM, Maher JW (2008) Does diabetes affect weight loss after gastric bypass? Surg Obes Relat Dis 4(3):441–444Google Scholar
  25. 25.
    Chikunguwo SM, Wolfe LG, Dodson P, Meador JG, Baugh N, Clore JN, Kellum JM, Maher JW (2010) Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass. Surg Obes Relat Dis 6(3):254–259Google Scholar
  26. 26.
    Cummings DE (2009) Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery. Int J Obes (Lond) 33(Suppl 1):S33–S40CrossRefGoogle Scholar
  27. 27.
    DiGiorgi M, Rosen DJ, Choi JJ, Milone L, Schrope B, Olivero-Rivera L, Restuccia N, Yuen S, Fisk M, Inabnet WB, Bessler M (2010) Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up. Surg Obes Relat Dis 6(3):249–253CrossRefPubMedGoogle Scholar
  28. 28.
    Hall TC, Pellen MG, Sedman PC, Jain PK (2010) Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity. Obes Surg 20(9):1245–1250CrossRefPubMedGoogle Scholar
  29. 29.
    Melton GB, Steele KE, Schweitzer MA, Lidor AO, Magnuson TH (2008) Suboptimal weight loss after gastric bypass surgery: correlation of demographics, comorbidities, and insurance status with outcomes. J Gastrointest Surg 12(2):250–255CrossRefPubMedGoogle Scholar
  30. 30.
    Vetter ML, Cardillo S, Rickels MR, Iqbal N (2009) Narrative review: effect of bariatric surgery on type 2 diabetes mellitus. Ann Intern Med 150(2):94–103CrossRefPubMedGoogle Scholar
  31. 31.
    Sarson DL, Scopinaro N, Bloom SR (1981) Gut hormone changes after jejunoileal (JIB) or biliopancreatic (BPB) bypass surgery for morbid obesity. Int J Obes 5(5):471–480PubMedGoogle Scholar
  32. 32.
    Sugerman HJ, Wolfe LG, Sica DA, Clore JN (2003) Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg 237(6):751–756PubMedCentralPubMedGoogle Scholar
  33. 33.
    Lee WJ, Chong K, Ser KH, Lee YC, Chen SC, Chen JC, Tsai MH, Chuang LM (2011) Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus. A randomized controlled trial. Arch Surg 146(2):143–148CrossRefPubMedGoogle Scholar
  34. 34.
    Zervos E, Agle SC, Warren AJ, Lang CG, Fitzgerald TL, Dar M, Rotondo MF, Pories WJ (2010) Amelioration of insulin requirement in patients undergoing duodenal bypass for reasons other than obesity implicates foregut factors in the pathophysiology of type II diabetes. J Am Coll Surg 210(5):564–572, 572–574Google Scholar
  35. 35.
    Nannipieri M, Mari A, Anselmino M, Baldi S, Barsotti E, Guarino D, Camastra S, Bellini R, Berta RD, Ferrannini E (2011) The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery. J Clin Endocrinol Metab 96(9):E1372–E1379CrossRefPubMedGoogle Scholar
  36. 36.
    Cummings S, Apovian CM, Khaodhiar L (2008) Obesity surgery: evidence for diabetes prevention/management. J Am Diet Assoc 108(4 Suppl 1):S40–S44CrossRefPubMedGoogle Scholar
  37. 37.
    Koner J, Inabnet W, Febres G, Conwell IM, McMahon DJ, Salas R, Taveras C, Schrope B, Bessler M (2009) Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass. Int J Obes (Lond) 33(7):786–795CrossRefGoogle Scholar
  38. 38.
    Laferrère B, Heshka S, Wang K, Khan Y, McGinty J, Teixeira J, Hart AB, Olivan B (2007) Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care 30(7):1709–1716PubMedCentralCrossRefPubMedGoogle Scholar
  39. 39.
    Mingrone G, Castagneto-Gissey L (2009) Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery. Diabetes Metab 35(6 Pt 2):518–523CrossRefPubMedGoogle Scholar
  40. 40.
    Morínigo R, Moizé V, Musri M, Lacy AM, Navarro S, Marín JL, Delgado S, Casamitjana R, Vidal J (2006) GLP-1, PYY, hunger and satiety following gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 91(5):1735–1740CrossRefPubMedGoogle Scholar
  41. 41.
    Pournaras DJ, Osbrone A, Hawkins S, Vincent RP, Mahon D, Ewings P, Ghatei MA, Bloom SR, Welbourn R, le Roux CW (2010) Remission of type 2 diabetes after gastric bypass and banding: mechanism and 2 year outcomes. Ann Surg 252(6):966–971CrossRefPubMedGoogle Scholar
  42. 42.
    Lee WJ, Chong K, Chen CY, Chen SC, Lee YC, Ser KH, Chuang LM (2011) Diabetes remission and insulin secretion after gastric bypass in patients with body mass index <35 kg/m2. Obes Surg 21(7):889–895CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Martino Guenzi
    • 1
    • 2
  • Gustavo Arman
    • 1
    • 2
  • Cédric Rau
    • 1
    • 2
  • Cristiana Cordun
    • 1
    • 2
  • David Moszkowicz
    • 1
    • 2
  • Thibault Voron
    • 1
    • 2
  • Jean-Marc Chevallier
    • 1
    • 2
  1. 1.Department of Digestive SurgeryHôpital Européen Georges PompidouParisFrance
  2. 2.Assistance Publique-Hôpitaux de Paris, University Paris 5ParisFrance

Personalised recommendations